Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).

Tubiana R, Le Chenadec J, Rouzioux C, Mandelbrot L, Hamrene K, Dollfus C, Faye A, Delaugerre C, Blanche S, Warszawski J.

Clin Infect Dis. 2010 Feb 15;50(4):585-96. doi: 10.1086/650005.

PMID:
20070234
2.

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L; ANRS French Perinatal Cohort..

AIDS. 2008 Jan 11;22(2):289-99.

PMID:
18097232
3.

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.

European Collaborative Study..

Clin Infect Dis. 2005 Feb 1;40(3):458-65. Epub 2005 Jan 7.

PMID:
15668871
4.

Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?

Jasseron C, Mandelbrot L, Tubiana R, Teglas JP, Faye A, Dollfus C, Le Chenadec J, Rouzioux C, Blanche S, Warszawski J; ANRS French Perinatal Cohort..

AIDS. 2008 Jul 31;22(12):1503-11. doi: 10.1097/QAD.0b013e3283065b8c.

PMID:
18614874
5.

The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group.

Thea DM, Steketee RW, Pliner V, Bornschlegel K, Brown T, Orloff S, Matheson PB, Abrams EJ, Bamji M, Lambert G, Schoenbaum EA, Thomas PA, Heagarty M, Kalish ML.

AIDS. 1997 Mar 15;11(4):437-44.

PMID:
9084790
6.

Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.

Palacios R, Senise J, Vaz M, Diaz R, Castelo A.

HIV Med. 2009 Mar;10(3):157-62. doi: 10.1111/j.1468-1293.2008.00665.x.

7.

Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group.

Mayaux MJ, Dussaix E, Isopet J, Rekacewicz C, Mandelbrot L, Ciraru-Vigneron N, Allemon MC, Chambrin V, Katlama C, Delfraissy JF, Puel J.

J Infect Dis. 1997 Jan;175(1):172-5.

PMID:
8985214
8.

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA 3rd, Whitehouse J, Moye J Jr, Reichelderfer P, Harris DR, Fowler MG, Mathieson BJ, Nemo GJ.

N Engl J Med. 1999 Aug 5;341(6):385-93.

9.

Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial.

Leroy V, Montcho C, Manigart O, Van de Perre P, Dabis F, Msellati P, Meda N, You B, Simonon A, Rouzioux C; DITRAME Study Group..

AIDS. 2001 Mar 9;15(4):517-22.

PMID:
11242149
10.

Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group.

Mock PA, Shaffer N, Bhadrakom C, Siriwasin W, Chotpitayasunondh T, Chearskul S, Young NL, Roongpisuthipong A, Chinayon P, Kalish ML, Parekh B, Mastro TD.

AIDS. 1999 Feb 25;13(3):407-14.

PMID:
10199232
12.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
13.

Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?

Galli L, Puliti D, Chiappini E, Gabiano C, Ferraris G, Mignone F, ViganĂ² A, Giaquinto C, Genovese O, Anzidei G, Badolato R, Buffolano W, Maccabruni A, Salvini F, Cellini M, Ruggeri M, Manzionna M, Bernardi S, Tovo P, de Martino M; Italian Register for HIV Infection in Children..

Clin Infect Dis. 2009 May 1;48(9):1310-7. doi: 10.1086/597774.

PMID:
19309307
14.

Mortality during the first 24 months after delivery in relation to CD4 T-lymphocyte levels and viral load in a cohort of breast-feeding HIV-1-infected women in Dar es Salaam, Tanzania.

Kilewo C, Karlsson K, Swai A, Massawe A, Lyamuya E, Mhalu F, Biberfeld G.

J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):598-602.

PMID:
15793372
15.

Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10).

Dollfus C, Le Chenadec J, Faye A, Blanche S, Briand N, Rouzioux C, Warszawski J.

Clin Infect Dis. 2010 Jul 15;51(2):214-24. doi: 10.1086/653674.

PMID:
20536367
16.

Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group.

Rich KC, Fowler MG, Mofenson LM, Abboud R, Pitt J, Diaz C, Hanson IC, Cooper E, Mendez H.

Pediatrics. 2000 Jan;105(1):e8.

PMID:
10617745
19.

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.

Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Moye J, Hanson C, Zorrilla C, Lew JF.

N Engl J Med. 1999 Aug 5;341(6):394-402.

20.

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

Ioannidis JP, Abrams EJ, Ammann A, Bulterys M, Goedert JJ, Gray L, Korber BT, Mayaux MJ, Mofenson LM, Newell ML, Shapiro DE, Teglas JP, Wilfert CM.

J Infect Dis. 2001 Feb 15;183(4):539-45. Epub 2001 Jan 12.

PMID:
11170978

Supplemental Content

Support Center